Two de novo BCL11A heterozygous variants were reported to be associated with patients with epileptic encephalopathy (Yoshida et al., 2018), and it also indicated that a de novo mutation in the BCL11A gene result in epilepsy (Korenke et al., 2020). The gene discussed is BCL11A; the disease is epilepsy.